Dr. Wan Zhaokui, founder and CEO of Lingke Pharmaceutical. PhD from Boston University, postdoctoral fellow at Harvard University, and former Senior Chief Scientist at Pfizer in the United States; Director and Head of Chemistry Department at Johnson&Johnson. With over 20 years of experience in new drug research and development, I have been involved in various knowledge fields of new drug research. In the past 20 years of scientific research, I have published more than 40 research articles and 485 global/national patents! In 2008, Dr. Wan was selected as an outstanding young scientist in the industrial sector by the American Chemical Society; Selected as a Fellow of the Royal Society of Chemistry in 2015; In 2017, he was elected as a member of the Executive Committee on Cancer Chemistry Research of the American Cancer Society and served as an editorial board member for the association's newsletter. Dr. Wan is also a co-founder, board member, and former president of the US China Biomedical Association (CABA).